vimarsana.com
Home
Live Updates
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States : vimarsana.com
USFDA Approves LaNeo MDMA for Clinical Trial Use in the United States
Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the... | June 10, 2023
Related Keywords
United Kingdom ,
Australia ,
United States ,
Canada ,
Denver ,
Colorado ,
Vancouver ,
British Columbia ,
British ,
Canadian ,
David Purcell ,
Nick Kadysh ,
Nicholas Kadysh ,
Harpreet Kaur ,
Pharmala Biotech Holdings Inc ,
Neither The Canadian Securities Exchange ,
Vitura Health ,
Prescriber Program ,
Regulation Services Provider ,
Health Canada ,
Research At Pharmala Biotech ,
Drug Administration ,
Approved Study ,
Examine Tolerability ,
Ala Biotech Holdings ,
Medical Product ,
Vice President ,
Authorized Prescriber Program ,
Joint Venture ,
Sales Director David Purcell ,
Psychedelic Science ,
Canadian Securities Exchange ,
vimarsana.com © 2020. All Rights Reserved.